Effects of Soy Isoflavone on Hepatic Fatty Acid Metabolism of Rats
Ping CHEN,Li-ke LI,Xiao-lin CHEN,Yi-fan LI,Qi-hui LUO,Chao HUANG,Wen-tao LIU,Zheng-li CHEN
DOI: https://doi.org/10.16036/j.issn.1000-2650.2018.02.020
2018-01-01
Abstract:[Objective]The experiment was designed to study the effects of different doses of soy isoflavones on fatty acid metabolism of rat liver and its mechanism.[Method]Forty rats in 6 month were randomly divided into control,low,middle and high groups,ten rats per group. The rats were given by gavage different doses of soy isoflavones (0,50,250,500 mg/kg)last for 4 weeks,and recorded the body weight every week;RT-PCR were used to test the mRNA levels of SREBP-1c,ACC1,FAS,PPARα and ATGL.[Result]The results showed that:compared with control group,rats in middle and high groups exhibited decreased body weight(P<0.01).TG in low group rats decreased significantly(P<0.05),TC,TG and LDL-c decreased in middle group(P<0.05),TG and LDL-c extremely decreased in high group (P<0.01);No ab-normal pathological changes in liver by HE staining,but there were little lipid droplets left in the liver of middle and high group rats by oil red staining;the mRNA expression of FA S,A CC1 in liver was significantly decreased in low group rats (P<0.01),and FA S,SREBP-1C and A CC-1mRNA were also decreased among middle and high groups(P<0.05 or P<0.01),however,the levels of PPA Rα and A TGL were signif-icantly increased(P<0.05 or P<0.01).[Conclusion]All the results indicated that soy isoflavones can affect hepatic fatty acid metabolism by down-regulation the expression of SREBP-1c,A CC1 and FA S,but promoting the expression of SREBP-1c,A CC1 and FA S.